Gapping down
In reaction to disappointing earnings/guidance:
- JKS -5.8%, MMM -2.6% (May sales)
Select ETFs showing early weakness:
- XLE -3.9%, XLF -3.3%, IWM -3%, DIA -2.4%, SPY -2.1%, IGV -2.1%, QQQ -1.5%
Other news:
- HTZ -24.4% (reports circulate indicating that the company has received approval for its proposed stock sale from a bankruptcy judge)
- XPO -5.1% (provides list of actions taken to combat COVID-19 ahead of industry summit)
- BP -4.6% (revises long-term price assumptions, reviews intangible assets and, as a result, expects non-cash impairments and write-offs)
- BLDP -3.9% (files final short form base shelf prospectus, which provides the flexibility to make offerings of securities during the effective period of the Prospectus, until July 2022)
- CTVA -3.8% (files motion to intervene in legal challenge to EPA registrations of Dicamba products)
Analyst comments:
- MAC -6.2% (downgraded to Underperform from In-line at Evercore ISI)
- VTR -3.6% (downgraded to Underperform from In-line at Evercore ISI)
- EQNR -2.3% (downgraded to Sell from Neutral at Goldman)
- KIM -2% (downgraded to Underperform from In-line at Evercore ISI)
- DEO -1.6% (downgraded to Neutral from Outperform at Credit Suisse)